Recent Publications

Accordion Widget

  • Xu C, Mullersman JE, Wang L, Bin Su B, Mao C, Posada Y, Camarillo C, Mao Y,Escamilla MA, Wang KS. Polymorphisms in seizure 6-like gene are associated with bipolar disorder I: Evidence of gene x gender interaction. J Affect Disord. 2012 Aug 21. [Epub ahead of print]

  • Gara MA, Vega WA, Arndt S, Escamilla M, Fleck DE, Lawson WB, Lesser I, Neighbors HW, Wilson DR, Arnold LM, Stratowski SM. Influence of patient race and ethnicity on clinical assessment in patients with affective disorders. Arch Gen Psychiatry. 2012 Jun;69(6):593-600.

  • Hare E, Contreras J, Raventos H, Flores D, Jerez A, Nicolini H, Ontiveros A, Almasy L, Escamilla M. Genetic structure of personality factors and bipolar disorder in families segregating bipolar disorder. J Affect Disord. 2012 Feb;136(3):1027-33. Epub 2011 Sep 7.

  • Briones DF, Heller PL, Carcoba LM, Weisman HW, Ledger EM, Escamilla MA. Health-related conditions and depression in elderly mexican american and non-Hispanic white residents of a United States-Mexico border county: moderating effects of educational attainment. Depress Res Treat. 2011;2011:908536. Epub 2011 Aug 15.

  • Contreras J, Hare E, Escamilla M, Raventos H. Principal domains of quantitative anxiety trait in subjects with lifetime history of mania. J Affect Disord. 2012 Jan;136(1-2):e69-75. Epub 2011 Jul 19.

  • Jimenez-Castro L, Raventos-Vorst H, Escamilla M. Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population. Actas Esp Psiquiatr. 2011 Mar-Apr;39(2):123-30. Epub 2011 Mar 1.

  • Segura-Wang M, Raventos H, Escamilla M, Barrantes R. Assessment of genetic ancestry and population substructure in Costa Rica by analysis of individuals with a familial history of mental disorder. Ann Hum Genet. 2010 Nov;74(6):516-24. doi: 10.1111/j.1469-1809.2010.00612.x. Epub2010 Oct 6.

  • Baig MR, Navaira E, Escamilla MA, Raventos H, Walss-Bass C. Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells: a possible mechanism for antipsychotic-induced metabolic alterations. J Psychiatr Pract. 2010 Sep;16(5):325-33.

  • Gara MA, Vega WA, Lesser I, Escamilla M, Lawson WB, Wilson DR, Fleck DE, Strakowski SM. The role of complex emotions in inconsistent diagnoses of schizophrenia. J Nerv Ment Dis. 2010 Sep;198(9):609-13.

  • Marballi K, Quinones MP, Jimenez F, Escamilla MA, Raventos H, Soto-Bernardini MC, Ahuja SS, Walss-Bass C. In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation. J Mol Med (Berl). 2010 Nov;88(11):1133-41. Epub 2010 Jul 13.

  • Wilcox, James Allen, Gazarov, Aleksandr. Book Forum: Psychotic Disorders: Catatonia: From Psychopathology to Neurobiology. Am J Psychiatry 162:1987-a-1988, October 2005.

  • Briones, David F., Wilcox, James A., Mateus, Beatriz A., Boudjenah, Djillali. Risk Factors and Prevention in Adolescent Substance Abuse: A Biopsychosocial Approach. IN PRESS: Adolescent Medicine Clinics, 2005.

  • Heller, Peter L., Briones, David F., Schiffer, Randolph B., Guerrero, Martin, Royall, Donald R., Wilcox, James A., Ledger, Elizabeth M. Mexican-American Ethnicity and Cognitive Function: Findings from an Elderly Southwestern Sample. IN PRESS: Journal of Neuropsychiatry and Behavioral Science, 2005.

  • Wilcox, J.A., Book Review: Treatment Matching in Alcoholism. American Journal of Psychiatry, August 2004; 161:1514.

  • Guerrero, Martin and Heller, Peter L. Cultural Limits in Informed Consent with Dementia Research. Alzheimer Disease and Associated Disorders, April-June, 17, 2003, Supplement 1, S26-30.

  • Wilcox, J.A., Book Review: Neurochemistry of Consciousness: Neurotransmitters in Mind. American Journal of Psychiatry, October 2003; 160: 1896a-97.

  • Giordano, Frank L., Briones, David F. Assessing Residents' Competence in Psychotherapy. Academic Psychiatry, 27:3, Fall 2003, 145-7.

  • Wilcox, J.A., Tsuang M.T., Schnurr, T., Baida-Fragoso, N. Case-control family study of lesser variant traits in autism. Neuropsychobiology, 2003; 47(4): 171-7.

  • Briones, David F., Heller, Peter L., Guerrero, Martin , Schiffer, Randolph B., Wilcox, James A., Ledger, Elizabeth M., Cutter, Minerva L. Cultural vs. Educational Bias in Three Widely-Used Cognitive Screening Instruments Among Elderly Mexican-American and Non-Hispanic White Residents of El Paso County , Texas . Texas/World Health Organization Collaborating Center Proceedings of the Annual Meetings on Cross-Cultural Research and Training on Mental Health and Psychosocial Factors in Health in Mexico and Texas , Spring 2002.

  • Wilcox, J.A. Book Review: Schizophrenia Revealed: From Neurons to Social Interactions. American Journal of Psychiatry, August 2002; 159: 1450-51.

  • Briones, David F. Book Review: Bipolar Disorders, Clinical Course and Outcome. Journal of Depressive Disorders, Fall 2002.

  • Giordano, Frank L. Book Review: How to Effectively Organize Your Interview, Oral Presentation, and Video Exam. In press, Soar Dime Limited, Fall 2002.

  • Briones, David F., Ramirez, Arthur L., Guerrero, Martin and Ledger, Elizabeth . Determining Cultural and Psychosocial Factors in Alzheimer Disease Among Hispanic Populations. Alzheimer Disease and Associated Disorders, 16 Supplement 2:S86-8, 2002.

  • Wilcox, J., Tsuang, M., Ledger, E., Algeo, J., Schnurr, T. Brain Perfusion in Autism Varies with Age. Neuropsychobiology, 46:13-16, 2002.

  • Wilcox, J. Book Review: Schizophrenia in Children and Adolescents. American Journal of Psychiatry, 159:4, p. 685, 2002.

  • Wilcox, J.A., Ramirez, A.L. Book Review: Handbook of Substance Abuse: Neurobehavioral Pharmacology. American Journal of Psychiatry; April 2001, 158: 669.

  • Wilcox, James and Guerrero, Martin. Bipolar Disorder, the Economics of Treatment. Annals of Clinical Psychiatry, vol. 13, no.1: 60-61, 2001.

  • Wilcox, James and Baida-Fragoso, Nicolas. Impulse Reduction and Suicide Prevention. Annals of Clinical Psychiatry, vol. 13, no.1: 59-60, 2001.

  • Wilcox, J.A. Book Review: Clinical Textbook of Addictive Disorders, 2 nd edition. American Journal of Psychiatry, August 1999; 156: 1287-88.

  • Neuman, Mark, and Wilcox, James. Depression: The Diagnostic Enigma. The El Paso Physician, September 1999.

The titles are block, so you don't have to click the text part to activate it

  • Indicators for expand / collapsing items
  • Removed title links (hover underlinings, and outlines).
  • The Study of Olanzapine plus Fluoxetine in Combination for Treatment-resistant Depression without Psychotic Features, David F. Briones, M.D., Eli Lilly and Company, $256,423.

  • An International, Multicenter Large Simple Trial (LST) to Compare the Cardiovascular Safety of Ziprasidone and Olanzapine, Martin Guerrero, M.D., Pfizer, $6000.

  • Alzheimer's Disease in El Paso 's Residential Elderly Population, Martin Guerrero, M.D., Center for Border Health Research, $75,000.

  • A Mastery-Based Weight Prevention Program for the Management of Antipsychotic-Related Weight Gain Among Mexican-American Patients: A Pilot Project, David F. Briones, M.D., Eli Lilly and Company, $73,250.

  • An Olanzapine Model for Relieving Anxiety in Schizophrenic Patients and Implications for Enhanced Compliance, Arthur L. Ramirez, M.D., Eli Lilly and Company, $24,648.

  • A Randomized Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia, Martin Guerrero, M.D., Eli Lilly and Company.

  • A Neurogenetic Investigation of Patients with Schizophrenia Spectrum Disorders and Participating Family Members, James A. Wilcox, D.O., Ph.D., National Institute of Mental Health.

  • Surveillance for Multiple Sclerosis and Amyotrophic Lateral Sclerosis in Texas, Richard Brower, M.D., Texas Department of Health.
  • Olanzapine versus Ziprasidone in the Treatment of Schizophrenia, James A. Wilcox, D.O., Eli Lilly and Company, $177,415.

  • A Controlled Trial of Olanzapine versus Ziprasidone in the Treatment of Schizophrenic and Schizoaffective Subjects with Comorbid Depression, Martin Guerrero, M.D., Eli Lilly and Company, $135,026.

  • A Comparison of Fasting Triglyceride Levels in Cohorts with Schizophrenia and Related Disorders Treated Chronically with Olanzapine, Risperidone, and Typical Antipsychotics, David F. Briones, M.D., Eli Lilly and Company, $30,917.

  • A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Evaluation of Lamotrigine Adjunctive Therapy in Subjects with Primary Generalized Tonic-clonic Seizures, Richard D. Brower, M.D., GlaxoSmithKline.

  • Lilly F1D-MC-HGHZ The combination of olanzapine and fluoxetine in treatment-resistant depression without psychotic features.

  • Lilly F1D-MC-HGJX A comparison of fasting triglyceride levels in cohorts with schizophrenia and related disorders treated chronically with olanzapine, risperidone and typical antipsychotics.

  • Lilly F1D-US-HGJU A controlled trial of olanzapine versus ziprasidone in the treatment of schizophrenic and schizoaffective subjects with comorbid depression.

  • Lilly F1D-MC-HGHJ Olanzapine versus ziprasidone in the treatment of schizophrenia.

  • Lilly F1D-MC-HGGY Placebo-controlled monotherapy in the treatment of bipolar I depression.

  • Center for Border Health Research Psychological distress among elderly Hispanic and Anglo residents of El Paso, Texas.